Stanley M. Crain
18Patents
14h-index
15Co-inventors
75Inventor score
Filing activity: Jul 27, 1993 → Nov 5, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6096756A | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists | Physics | 239 | Expired |
| US5472943A | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists | Physics | 234 | Expired |
| US5512578A | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists | Physics | 147 | Expired |
| US5767125A | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists | Physics | 133 | Expired |
| US5580876A | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists | Physics | 128 | Expired |
| US5585348A | Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia | Emerging Cross-Sectional Technologies | 115 | Expired |
| US6194382A | Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists | Human Necessities | 91 | Expired |
| US6395705B2 | Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists | Human Necessities | 85 | Expired |
| US5624932A | Method for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addiction | Physics | 85 | Expired |
| US6362194B1 | Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists | Physics | 77 | Expired |
| US7026329B2 | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists | Physics | 76 | Expired |
| US6765010B2 | Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects | Human Necessities | 75 | Expired |
| USRE36547E | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists | General | 62 | Expired |
| US8741319B2 | Methods and compositions for treating anxiety disorders or symptoms thereof | Human Necessities | 22 | Active |
| US8202525B2 | Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications | Human Necessities | 14 | Active |
| US8372414B2 | Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications | Human Necessities | 8 | Active |
| US8617577B2 | Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications | Human Necessities | 7 | Active |
| US6737400B2 | Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists | Human Necessities | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.